Oxime reactivators of acetylcholinesterase are commonly used to treat highly toxic organophosphate poisoning. They are effective nucleophiles that can restore the catalytic activity of acetylcholinesterase; however, their main limitation is the difficulty in crossing the blood-brain barrier (BBB) because of their strongly hydrophilic nature. Various approaches to overcome this limitation and enhance the bioavailability of oxime reactivators in the CNS have been evaluated; these include structural modifications, conjugation with molecules that have transporters in the BBB, bypassing the BBB through intranasal delivery, and inhibition of BBB efflux transporters. A promising approach is the use of nanoparticles (NPs) as the delivery systems. Studies using mesoporous silica nanomaterials, poly (L-lysine)-graft-poly(ethylene oxide) NPs, metallic organic frameworks, poly(lactic-co-glycolic acid) NPs, human serum albumin NPs, liposomes, solid lipid NPs, and cucurbiturils, have shown promising results. Some NPs are considered as nanoreactors for organophosphate detoxification; these combine bioscavengers with encapsulated oximes. This study provides an overview and critical discussion of the strategies used to enhance the bioavailability of oxime reactivators in the central nervous system.

Biomedical Research Centre University Hospital in Hradec Kralove Sokolska 581 500 05 Hradec Kralove Czech Republic

Faculty of Science Department of Chemistry University of Hradec Kralove Rokitanskeho 62 500 03 Hradec Kralove Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23016058

003      

CZ-PrNML

005      

20231026110519.0

007      

ta

008      

231013s2023 gw f 000 0|eng||

009      

AR

024    7_

$a 10.1007/s00204-023-03587-0 $2 doi

035    __

$a (PubMed)37642747

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a gw

100    1_

$a Prchalova, Eliska $u Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000302270007

245    10

$a Strategies for enhanced bioavailability of oxime reactivators in the central nervous system / $c E. Prchalova, Z. Kohoutova, K. Knittelova, D. Malinak, K. Musilek

520    9_

$a Oxime reactivators of acetylcholinesterase are commonly used to treat highly toxic organophosphate poisoning. They are effective nucleophiles that can restore the catalytic activity of acetylcholinesterase; however, their main limitation is the difficulty in crossing the blood-brain barrier (BBB) because of their strongly hydrophilic nature. Various approaches to overcome this limitation and enhance the bioavailability of oxime reactivators in the CNS have been evaluated; these include structural modifications, conjugation with molecules that have transporters in the BBB, bypassing the BBB through intranasal delivery, and inhibition of BBB efflux transporters. A promising approach is the use of nanoparticles (NPs) as the delivery systems. Studies using mesoporous silica nanomaterials, poly (L-lysine)-graft-poly(ethylene oxide) NPs, metallic organic frameworks, poly(lactic-co-glycolic acid) NPs, human serum albumin NPs, liposomes, solid lipid NPs, and cucurbiturils, have shown promising results. Some NPs are considered as nanoreactors for organophosphate detoxification; these combine bioscavengers with encapsulated oximes. This study provides an overview and critical discussion of the strategies used to enhance the bioavailability of oxime reactivators in the central nervous system.

650    _2

$a lidé $7 D006801

650    _2

$a biologická dostupnost $7 D001682

650    12

$a acetylcholinesterasa $7 D000110

650    12

$a centrální nervový systém $7 D002490

650    _2

$a hematoencefalická bariéra $7 D001812

650    _2

$a biologický transport $7 D001692

655    _2

$a časopisecké články $7 D016428

655    _2

$a přehledy $7 D016454

700    1_

$a Kohoutova, Zuzana $u Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000333823997

700    1_

$a Knittelova, Karolina $u Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000251878986

700    1_

$a Malinak, David $u Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic. david.malinak@uhk.cz $u Biomedical Research Centre, University Hospital in Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. david.malinak@uhk.cz $1 https://orcid.org/0000000206650667

700    1_

$a Musilek, Kamil $u Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic. kamil.musilek@uhk.cz $u Biomedical Research Centre, University Hospital in Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. kamil.musilek@uhk.cz $1 https://orcid.org/0000000275044062 $7 xx0135628

773    0_

$w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 97, č. 11 (2023), s. 2839-2860

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37642747 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20231013 $b ABA008

991    __

$a 20231026110513 $b ABA008

999    __

$a ok $b bmc $g 1999907 $s 1202420

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 97 $c 11 $d 2839-2860 $e 20230829 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265

GRA    __

$a GA22-14568S $p Grantová Agentura České Republiky

GRA    __

$a CZ.02.2.69/0.0/0.0/19_073/0016949 $p Ministerstvo Školství, Mládeže a Tělovýchovy

LZP    __

$a Pubmed-20231013